Targeted Delivery of Interferon Gamma Using a Recombinant Fusion Protein of a Fibrin Clot-Binding Peptide With Interferon Gamma for Cancer Gene Therapy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Pharmacy and Science

• Publication date

  2017-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.xphs.2016.11.018PMID 27939375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo

  2015cited by this paper
• Selective delivery of IFN‐γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis

  2015cited by this paper
• Prevention of adverse events of interferon γ gene therapy by gene delivery of interferon γ-heparin-binding domain fusion protein in mice

  2014cited by this paper
• Enhancement of anticancer effect of interferon-γ gene transfer against interferon-γ-resistant tumor by depletion of tumor-associated macrophages.

  2014cited by this paper
• Tumor targeting and microenvironment-responsive nanoparticles for gene delivery.

  2013cited by this paper
• Discovery of an uncovered region in fibrin clots and its clinical significance

  2013cited by this paper
• Long-Term Elimination of Hepatitis C Virus from Human Hepatocyte Chimeric Mice After Interferon-γ Gene Transfer

  2013cited by this paper
• Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.

  2013cited by this paper
• Constant and steady transgene expression of interferon‐γ by optimization of plasmid construct for safe and effective interferon‐γ gene therapy

  2012cited by this paper
• Regulation of immunological balance by sustained interferon-γ gene transfer for acute phase of atopic dermatitis in mice

  2012cited by this paper
• The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

  2011cited by this paper
• Prolonged circulation half-life of interferon γ activity by gene delivery of interferon γ-serum albumin fusion protein in mice.

  2011cited by this paper
• PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis.

  2011cited by this paper
• Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.

  2011cited by this paper
• Sustained Exogenous Expression of Therapeutic Levels of IFN-γ Ameliorates Atopic Dermatitis in NC/Nga Mice via Th1 Polarization

  2010cited by this paper
• Nanoparticle-induced vascular blockade in human prostate cancer.

  2010cited by this paper
• Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression

  2009cited by this paper
• Biomimetic amplification of nanoparticle homing to tumors

  2007cited by this paper
• Improved anti‐cancer effect of interferon gene transfer by sustained expression using CpG‐reduced plasmid DNA

  2007cited by this paper
• Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

  2007cited by this paper
• Cancer and venous thromboembolism.

  2005cited by this paper
• A phase I trial of recombinant gamma interferon in patients with cancer

  2004cited by this paper
• Interferon- : an overview of signals, mechanisms and functions

  2004cited by this paper
• Interferon-gamma: an overview of signals, mechanisms and functions.

  2004cited by this paper
• Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA

  1999cited by this paper
• Pegylated liposomal doxorubicin (DOXIL®, CAELYX®) distribution in tumour models observed with confocal laser scanning microscopy

  1998cited by this paper
• Cancer and venous thromboembolism.

  1987cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• Regulation of extravascular coagulation by microvascular permeability.

  1985cited by this paper

• Recent advances, strategies, and future perspectives of peptide-based drugs in clinical applications.

  2025cites this paper
• Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy

  2021cites this paper
• Developments in Tumor Targeting and Internalizing Peptides

  2017cites this paper